Health Developments: Glucosamine's Dementia Link and Ebola's New Threat

Recent health news covers various pressing issues including the link between glucosamine and dementia progression, an Ebola outbreak in Congo, and promising results from Novartis' new muscle disease drug. There's also news about FDA approvals, Novo Nordisk's data breach, and significant U.S. funding to counter the Ebola outbreak.

In recent health news, glucosamine, a supplement often used for joint pain, has been linked to the progression of dementia, raising concerns among users and healthcare professionals.

An alarming Ebola outbreak has been reported in a crowded displacement camp in Congo, marking the first Ebola-related deaths there and prompting international response efforts.

Meanwhile, Novartis reports promising results from its newly acquired experimental drug for a rare muscle disease, and the FDA has approved the expanded use of a type 1 diabetes drug, highlighting significant advancements and challenges in the healthcare sector.